DocStoX is a free AI-powered research platform for Indian equity markets, covering 6,800+ NSE & BSE stocks with prices, fundamentals, 326 financial ratios, shareholding, FII/DII flows, F&O, IPOs, a visual screener and AI stock scoring.

Yes. DocStoX has a free tier covering stock research, the screener, FII/DII data and educational guides, plus a free MCP API tier (50 tool calls/day) for AI assistants. A Pro plan adds higher limits and advanced features.

What data does DocStoX cover?

Every NSE & BSE listed stock (6,800+ instruments): EOD and intraday prices, income statement / balance sheet / cash flow, 326 ratios, quarterly shareholding, promoter pledge, mutual-fund holdings, FII/DII flows, F&O and option-chain data, analyst forecasts, IPOs, corporate actions and news.

Can AI assistants like ChatGPT or Claude use DocStoX data?

Yes. DocStoX runs a public Model Context Protocol (MCP) server at https://mcp.docstox.com/mcp with 39 tools, so Claude, ChatGPT, Cursor and other MCP clients can pull Indian market data directly. Setup and a free key are at https://docstox.com/mcp.

All news

Neutral impactResults

Sumitomo Chemical India Limited — Outcome of Board Meeting

NSE 1 hr ago·27 Jul 2026, 7:57 am

Sumitomo Chemical India

Sumitomo Chemical India Limited has announced the financial results for the period ending June 30, 2026, following a board meeting. This disclosure is a standard regulatory requirement for listed companies to keep the market informed about their recent performance.

For investors, this update provides the latest data on the company's profitability and operational health. Reviewing the specific figures allows shareholders to assess the firm's current trajectory and compare it against previous quarters or market expectations.

Moving forward, investors should focus on the detailed breakdown of revenue streams and cost management. Monitoring the company's future guidance will be key to understanding how it plans to sustain its growth in the coming fiscal year.